Chu Dijon - Hopital Du Bocage

Dijon 21079

2 studies enrolling now · 4 studies all time

What they study most

Immune Thrombocytopenia, Immune Thrombocytopenia (ITP), Primary Systemic (AL) Amyloidosis, Von Willebrand Disease

Studies at this site

• Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders — Recruiting now
• A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia — Recruiting now
• The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis — Stopped early
• rVWF IN PROPHYLAXIS — Completed